COVID-19-associated Coagulopathy: Role of Vitamins D and K

Area of Science:

• Biochemistry
• Immunology
• Public Health

Background:

• Coronavirus disease 2019 (COVID-19) is associated with coagulopathy, increasing mortality, particularly in patients with comorbidities like diabetes and hypertension.
• Cardiovascular complications contribute significantly to COVID-19 mortality.
• Existing treatments for severe COVID-19 include anti-inflammatory corticosteroids and anticoagulants, but specific guidelines are lacking.

Purpose of the Study:

• To discuss the roles of vitamin D and vitamin K in general.
• To elucidate the involvement of vitamins D and K in COVID-19-related coagulopathy.
• To provide recommendations for vitamin D and K supplementation to counter COVID-19 complications.

Main Methods:

• Literature review and synthesis of existing research on vitamins D and K.
• Analysis of the impact of vitamin deficiencies on cardiovascular and diabetes conditions in the context of COVID-19.
• Discussion of the mechanisms linking vitamin deficiencies to coagulopathy.

Main Results:

• Vitamin D and K deficiencies can exacerbate pre-existing cardiovascular and diabetes conditions.
• These deficiencies are linked to an increased incidence of coagulopathy in COVID-19 patients.
• Coagulopathy in COVID-19 can lead to severe outcomes such as stroke and heart attack.

Conclusions:

• Vitamin D and K play crucial roles in regulating coagulation.
• Addressing deficiencies in these vitamins may be a viable strategy to manage COVID-19-associated coagulopathy.
• Supplementation with vitamins D and K could be beneficial for managing COVID-19, especially in at-risk populations.